Management of Neonatal Hemolytic Disease

Diagnostic Approach

The American Academy of Pediatrics recommends obtaining cord blood or immediate neonatal blood sample for blood type, Rh status, and direct antiglobulin test (DAT/direct Coombs test) when the mother is Rh-negative 3, 1
Measurement of total serum bilirubin (TSB) is crucial immediately after birth, as pallor suggests significant hemolysis with risk of rapid bilirubin rise and kernicterus 4, 3

The American Academy of Pediatrics suggests monitoring for hyperbilirubinemia progression every 4-6 hours initially, as infants with hemolytic disease can develop rapidly escalating bilirubin levels 4, 3
Assessing adequacy of feeding and hydration is important, as poor intake exacerbates hyperbilirubinemia 3

The American College of Obstetricians and Gynecologists recommends initiating intensive phototherapy immediately while awaiting laboratory results, as this is the primary treatment for hyperbilirubinemia to prevent kernicterus 5, 4
Consideration of packed red blood cell transfusion is necessary if hemoglobin is critically low or infant shows signs of cardiovascular compromise 6
The American College of Obstetricians and Gynecologists suggests using O-negative, CMV-negative, irradiated packed red blood cells for transfusion 7, 5

The American Academy of Pediatrics recommends plotting bilirubin levels on an hour-specific nomogram to determine risk zone and guide phototherapy or exchange transfusion decisions 4, 3
Maintenance of phototherapy targeting bilirubin levels below exchange transfusion thresholds is crucial, which vary by gestational age and risk factors 4, 3
Preparation for exchange transfusion is necessary if bilirubin approaches 25 mg/dL or reaches exchange transfusion threshold for gestational age, as kernicterus risk increases significantly above this level 4, 2
The American College of Obstetricians and Gynecologists suggests monitoring TSB or transcutaneous bilirubin every 4-6 hours during the active hemolysis phase 4, 3
Repeat hemoglobin/hematocrit every 12-24 hours to assess ongoing hemolysis 5
Observation for signs of acute bilirubin encephalopathy, such as lethargy, poor feeding, high-pitched cry, hypotonia, or seizures, is important 3
The American Academy of Pediatrics recommends continuing monitoring for late anemia (2-6 weeks after birth), as neonates with HDN often develop anemia requiring "top-off" transfusions due to suppressed erythropoiesis 7, 5
Weekly hemoglobin checks for 4-6 weeks are recommended to detect late anemia 7, 5

The American Academy of Pediatrics suggests not discharging until bilirubin is clearly declining and below the high-risk zone on the nomogram 4, 3
Ensuring follow-up within 24-48 hours of discharge with a qualified healthcare provider for weight check, feeding assessment, and bilirubin recheck is necessary 4, 3
Providing written instructions to parents about monitoring for jaundice progression and when to seek immediate care is important 3
Scheduling hematology follow-up at 2-4 weeks to monitor for late anemia requiring transfusion is recommended 7, 5